Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Liver Neoplasms × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 6 Pain 4 Neoplasms 4 Agnosia 4 Chronic Pain 3 Pancreatic Neoplasms 2 Cancer Pain 2 Breast Neoplasms 2 Wounds and Injuries 1 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Ulcer 1 Thrombocythemia, Essential 1 Skin Ulcer 1 Signs and Symptoms 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pathologic Processes 1 Neurologic Manifestations 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

Radiosurgery 7 lenvatinib 5 Radiofrequency Ablation 5 Electroporation 5 Radiotherapy 3 Patient Navigation 3 Laparoscopy 3 Hepatectomy 3 Exercise 3 sintilimab 2 perflutren 2 Surgical Procedures, Operative 2 Standard of Care 2 Proton Therapy 2 Nutritional Status 2 Magnetic Resonance Spectroscopy 2 Liver Transplantation 2 Injections 2 Dextrins 2 Cryosurgery 2 Control Groups 2 Bupivacaine 2 Anesthesia, General 2 toripalimab 1 tislelizumab 1 seocalcitol 1 pembrolizumab 1 motexafin gadolinium 1 gadofosveset trisodium 1 gadobutrol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡